Epidermal hyperplasia induced by Raf-MAPK signaling requires Stat3 activation

Journal of Dermatological Science

Volumn 72, Issue 2, 2013, Pages 110-115

  Tarutani, Masahito ^a   Nakajima, Kimiko ^a   Takaishi, Mikiro ^a   Ohko, Kentaro ^a   Sano, Shigetoshi ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Epidermal hyperplasia; Knockout mice; Raf; Stat3; Transgenic mice

Indexed keywords

AFIMOXIFENE; CYTOKERATIN 14; CYTOKINE; ESTROGEN RECEPTOR; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAF PROTEIN; STAT3 PROTEIN; VASCULOTROPIN; LIGAND; STAT3 PROTEIN, MOUSE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; EPIDERMIS HYPERPLASIA; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PSORIASIS; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERPLASIA; KERATINOCYTE; KNOCKOUT MOUSE; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; EPIDERMIS; GENE EXPRESSION REGULATION; HUMANS; HYPERPLASIA; KERATINOCYTES; LIGANDS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION; PHENOTYPE; PSORIASIS; RAF KINASES; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TAMOXIFEN;

EID: 84885062451     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.06.007     Document Type: Article

References (20)

1. Crespo P., León J. Ras proteins in the control of the cell cycle and cell differentiation. Cell Mol Life Sci 2000, 57:1613-1636.
2. Dajee M., Tarutani M., Deng H., Cai T., Khavari P.A. Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation. Oncogene 2002, 21:1527-1538.
3. Tarutani M., Cai T., Dajee M., Khavari P.A. Inducible activation of Ras and Raf in adult epidermis. Cancer Res 2003, 63:319-323.
4. Shields J.M., Pruitt K., McFall A., Shaub A., Der C.J. Understanding Ras 'it ain't over 'til it's over'. Trends Cell Biol 2000, 10:147-154.
5. Krontiris T.G., Devlin B., Karp D.D., Robert N.J., Risch N. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med 1993, 329:517-523.
6. Pierceall W.E., Goldberg L.H., Tainsky M.A., Mukhopadhyay T., Ananthaswamy H.N. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 1991, 4:196-202.
7. Lin P., Baldassare J.J., Voorhees J.J., Fisher G.J. Increased activation of Ras in psoriatic lesions. Skin Pharmacol Appl Skin Physiol 1999, 12:90-97.
8. Tarutani M., Imai Y., Yasuda K., Tsutsui H., Nakanishi K., Yamanishi K. Neutrophil-dominant psoriasis-like skin inflammation induced by epidermal-specific expression of Raf in mice. J Dermatol Sci 2010, 58:28-35.
9. Sano S., Chan K.S., Carbajal S., Clifford J., Peavey M., Kiguchi K., et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005, 11:43-49.
10. Chan K.S., Sano S., Kiguchi K., Anders J., Komazawa N., Takeda J., et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 2004, 114:720-728.
11. Kim D.J., Angel J.M., Sano S., DiGiovanni J. Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis. Oncogene 2009, 28:950-960.
12. Sano S., Itami S., Takeda K., Tarutani M., Yamaguchi Y., Miura H., et al. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J 1999, 18:4657-4668.
13. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387.
14. Miyoshi K., Takaishi M., Nakajima K., Ikeda M., Kanda T., Tarutani M., et al. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol 2011, 131:108-117.
15. Chan K.S., Sano S., Kataoka K., Abel E., Carbajal S., Beltran L., et al. Forced expression on a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Oncogene 2007, 27:1087-1094.
16. Xia Y.P., Li B., Hylton D., Detmar M., Yancopoulos G.D., Rudge J.S. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003, 102:161-168.
17. Nakajima K. Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis. J Dermatol 2012, 39:219-224.
18. Nakajima K., Kanda T., Takaishi M., Shiga T., Miyoshi K., Nakajima H., et al. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model. J Immunol 2011, 186:4481-4489.
19. Fournier C., Tisman G. Sorafenib-associated remission of psoriasis in hypernephroma: case report. Dermatol Online J 2010, 16:17.
20. Zenz R., Eferl R., Kenner L., Florin L., Hummerich L., Mehic D., et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005, 437:369-375.